Fachliteratur Gastroenterologie: Neoplasien Pankreas

Fr | De

Feedback | Impressum | Sitemap

Keine Artikel ausgewählt!

Warenkorb

Sie sind hier: Fachliteratursuche » Pankreas » Neoplasie

25. Oktober 2026

Abklärungen / Diagnostik

Therapien

Guidelines

Fortbildung

News / Journalscreening

Schrift:

Seite 1 von 3098


	Artikel 1 - 20 / 61952

	Integrated single-cell and proteomic profiling of pancreatic neoplasia identifies tissue markers that outperform established diagnostic markers in distinguishing cancer from precursor lesions. medRxiv Tran TT, Nguyen-Hoang PU, Fahrmann JF, Pham DT, Bui H, Bui L, Schmidt CM. PMID: 42926779 [PubMed]
	The Economic Value of Hereditary Cancer Testing: A Systematic Review. Genet Med Kirshner C, Carter GC, Heald B, Hartzfeld D, Johnson H, Xiao J, Kong J, Thompson G, Sancar F, Peters ML. PMID: 42924496 [PubMed - as supplied by publisher]
	Atezolizumab plus Bevacizumab with or without Transarterial Chemoembolization as First-Line Treatment for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma: A Nationwide Multicenter Retrospective Study. Liver Cancer Zhang XW, Deng LW, Luo YG, Xie YF, Liu RB, Shao HB, Si TG, Feng DP, Wang J, Zhang Y, Li QD, Hu HT, Fan WJ, Song P, Yin LN, Wang Y, Chen Y, Lv TS, Xie Y, Hua TY, Xiao J, Nie RC, Shen LJ, Xuan ZM, Liu C, Yang XG, Chang X, Li X. PMID: 42924094 [PubMed - as supplied by publisher]
	Integrating Magnetic Resonance Imaging-Based Deep Learning and Radiomics to Predict Treatment Response in Hepatocellular Carcinoma Receiving Combined Systemic and Locoregional Therapies: A Multicenter Study. Liver Cancer Wang LN, Zhou SQ, Li F, Wu LF, Xu L, Wang K, Ge NL, Chen Y, Peng T, Song TQ, Yan ML, Zhang L, Zhou LD, Chen YJ, Zhu GD, Pan YX, Xue H, Zhu GZ, Liu DM, Zeng ZX, Hu K, Yang YC, Yang ZY, He T, Wang ZY, Huang C, Shen YH, Zhu XD, Li H, Gao Q, Zhou J, Fan J, Xu B, Sun HC, China Liver Cancer Study Group Young Investigators (CLEAP). PMID: 42924067 [PubMed - as supplied by publisher]
	Effects of combining durvalumab with chemotherapy in individuals suffering from advanced biliary tract cancer: an investigation into the prognostic nutritional index, systemic immune-inflammation index and patient survival outcomes. Am J Transl Res Zhang X, Jin S, Han J, Zhao X. PMID: 42923478 [PubMed]
	Clinical Outcomes of Gemcitabine Plus Nab-Paclitaxel-Based Chemoradiotherapy in a Multidisciplinary Treatment Strategy for Locally Advanced Pancreatic Cancer (NUPAT-05): AÂ Prospective, Single-Arm, Phase II Study. Int J Cancer Yamada H, Tanaka H, Yamada S, Takami H, Hayashi M, Nakagawa N, Kurimoto K, Inokawa Y, Watanabe N, Ishikawa T, Okumura M, Ogawa H, Ando M, Maeda O, Yamaguchi J, Naganawa S, Kawashima H, Fujii T, Yokoyama Y, Ebata T, Kanda M. PMID: 42922112 [PubMed - as supplied by publisher]
	A Hypoxia and EMT-Related Gene Signature for Predicting Prognosis and Immunotherapy Benefit in Hepatocellular Carcinoma. J Hepatocell Carcinoma Hu W, Gao D, Hou G, Liu C, Meng X, Liu Q, Sun J. PMID: 42921206 [PubMed]
	Autonomous AI research agents in pancreatic ductal adenocarcinoma immunology: from multimodal evidence to experimental validation. Front Immunol Li Y, Li Y, Huang R, San ZQ, Ye JF. PMID: 42921155 [PubMed - indexed for MEDLINE]
	Progress on therapeutic mRNA vaccines for cancer. Front Oncol Wu S, Liao H, Zhang W. PMID: 42920849 [PubMed]
	Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic cancer: the randomized phase 2 AMPLIFY-7P trial. Nat Med George B, Singh H, Devoe CE, Chung V, Hosein PJ, Hendifar A, Kim DW, Valerin JB, Bekaii-Saab T, Cardin DB, Hidalgo M, Kasi PM, Leal AD, Pelster M, Fei N, Weekes CD, O'Hara MH, George TJ, Kazmi SM, Mizrahi JD, Nair S, Maiers M, Kheoh T, Amato G, Xavier J, Snyder JP, Milaszewski MH, Cabana-Puig X, Perry JR, McNeil LK, Welkowsky E, DeMuth PC, Haqq CM, Pant S, Wainberg ZA, O'Reilly EM. PMID: 42919966 [PubMed - as supplied by publisher]
	Response to: "Re: 'Consensus-based validation of key quality indicators in pancreatic cancer surgery in Catalonia: a modified Delphi study'". Cir Esp (Engl Ed) Manchon-Walsh P, Sánchez-Velázquez P, Espín-Álvarez F, Guarga L. PMID: 42918326 [PubMed - as supplied by publisher]
	Re: "Consensus-based validation of key quality indicators in pancreatic cancer surgery in Catalonia: A modified Delphi study". Cir Esp (Engl Ed) Barzola E, Padillo J. PMID: 42918325 [PubMed - as supplied by publisher]
	Perioperative chemotherapy and stereotactic body radiotherapy versus perioperative chemotherapy alone in patients with high-risk, localised pancreatic cancer (MASTERPLAN): an open-label, phase 2, multicentre, randomised trial of the Australasian Gastro-Intestinal Trials Group. Lancet Oncol Oar A, Kneebone A, Sjoquist KM, Espinoza D, Lee M, Le H, Gholamrezaei L, Chu J, Lynam J, Mallesara G, Lee D, Vignarajah D, Ward I, Samra J, Barbour A, Whitehead A, Brooks S, Nicholson A, Wang TW, Ng W, Ali F, Siu D, Gaitan JL, Cook O, Moore A, Oostendorp MB, Yip S, Shakeshaft J, Pryor D, Nguyen N, Goldstein D, Australasian Gastro-Intestinal Trials Group (AGITG). PMID: 42914998 [PubMed - as supplied by publisher]
	Carbon ion radiotherapy for non-metastatic pancreatic cancer: final results of the prospective phase 2 PACK-study (NCT04194268). Radiother Oncol Liermann J, Naumann P, Jäkel C, Baumann L, Koczur B, Röhrich M, Englert FH, Jessen I, Tawk B, Knoll M, Baltazar F, Harrabi S, Springfeld C, Michalski C, Haberkorn U, Mairani A, Abdollahi A, Kieser M, Debus J, Herfarth K. PMID: 42913944 [PubMed - as supplied by publisher]
	Is it possible to predict resectability in pancreatic cancers? A retrospective study in a tertiary center. Cir Cir Ceylan C, Cengiz E, Kayaalp C, Aydin C. PMID: 42913615 [PubMed - indexed for MEDLINE]
	Durvalumab plus etoposide-carboplatin for advanced digestive neuroendocrine carcinoma: a phase III trial (JCOG2107E). Future Oncol Sano Y, Maruki Y, Morizane C, Nomura S, Fukuda H, Ikeda M, Ozaka M, Kobayashi S, Ohkawa K, Mizuno N, Tsumura H, Fujimori N, Komatsu Y, Takata N, Yasuda I, Nakachi K, Otsuru T, Honda T, Okusaka T, Ueno M, Hepatobiliary and Pancreatic Oncology Group in Japan Clinical Oncology Group. PMID: 42911120 [PubMed - as supplied by publisher]
	Metabolic Barriers to Cancer Immunotherapy: Multiscale Mechanisms from Organelle Dysfunction to Organ-Specific Constraints. Int J Biol Sci Gui Z, Yuan X, Chen X, Huang Q, Zhang B, Liang J. PMID: 42910256 [PubMed - indexed for MEDLINE]
	Effectiveness, safety, and retreatment outcomes in GEP-NET patients undergoing (177)Lu-based PRRT: a ten-year real-world experience. BMC Cancer Trinkl L, Thöne P, Dierneder J, Rumpold H. PMID: 42907811 [PubMed - indexed for MEDLINE]
	Pancreatic head solid-pseudopapillary neoplasm in a man treated by robot-assisted laparoscopic partial pancreatectomy: a case report. BMC Surg Ma R, Liu W, Yang Y, Tian X. PMID: 42907798 [PubMed - indexed for MEDLINE]
	Metabolomics and Biomarker Discovery. Adv Exp Med Biol Sinclair K, Dudley E. PMID: 42907622 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 61952

Seite 1 von 3098



		Zeitfenster

Ironmedline

Das Fachportal für Eisenmangel >>

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung